Cochlear Limited

Hearworks Pty, Limited

Peter Gibson

Fysh Dadd

Claudiu G Treaba

John Louis Parker

John Michael Heasman

Frank Risi

Luke Campbell

Stephen John O'Leary

David Walker

Charles Roger Aaron Leigh

Derek Ian Darley

Desmond A McCusker

Ian Darley

Katherine Meagher

Henry Hon Sang Tsui

Miroslaw Mackiewicz

Bastiaan Van Dijk

Edmond D Capcelea

Roger Leigh

Kerrie Plant

Lars Vendelbo Johansen

Paul Michael Carter

James Finlay Patrick

Peter Schuller

Christopher Joseph Long

Zachary Mark Smith

Jane Rapsey

Riaan Rottier

Robert Cowan

Bart Volckaerts

Ernst Lehnhardt

Carrie Newbold

Thomas Lenarz

Mark Alan Von Huben

Gordon George Wallace

Daniel Smyth

C Roger Leigh

Nicholas Charles Pawsey

Jim Patrick

Dezhi Zhou

Stuart Thomas

Miro Mackiewicz

Geoff Spinks

Elaine Saunders

Jin Xu

Robert Briggs

Sharam Manouchehri

Claudia Tasche

James William Leith Dalton

Horst Hessel

Minoo Lenarz

Claudia Treaba

Ya Ling Tam

Mary-Beth Brinson

Lars Johansen

Christofer William Bester

Claudiu Treaba

Ernst Von Wallenberg

Stephen O'leary

Desmond Mccusker

An example method includes obtaining vestibular biological state data and external sensor data over a period of time. Changes in one or both of the vestibular biological state data and the external sensor data over the period of time are monitored. The changes over time are used to determine a performance of the vestibular system of the recipient based on the changes.

Vestibular clinical support system functionality

Presented herein are techniques that make use of objective measurements obtained in response to acoustic stimulation signals. More specifically, at least one measure of outer hair cell function and at least one measure of auditory nerve function are obtained from a tonotopic region of an inner ear of a recipient of a hearing prosthesis. The at least one measure of auditory nerve function and the least one measure of outer hair cell function are then analyzed relative to one another.

Objective determination of acoustic prescriptions

Presented herein are techniques for assessing one or more outcomes associated with implantation of one or more electrodes into the inner ear of a recipient.

Inner ear electrode implantation outcome assessment

Presented herein are techniques for monitoring the insertion of an intra-cochlear stimulating assembly for the occurrence of one or more insertion stop conditions. The insertion stop conditions are detectable events indicating that movement of the stimulating assembly into a recipient's cochlea should be at least temporarily stopped. The insertion monitoring is based on objectively measured inner ear potentials, such as acoustically-evoked potentials.

Monitoring stimulating assembly insertion

Controlling the interaction between an external device and an implanted device, including a method of controlling interaction between an external device and an implanted device, the method including at least the steps of: establishing communications between the implanted device and the external device; the external device determining an identification of the implant and comparing the identification with identifications in a stored list; if the device matches one of said identifications, then using a corresponding set of operating parameters to interact with said implant; and otherwise, not interacting with said device.

Recognition of implantable medical device

A tip member for inserting into the cochlea, a device comprising: an elongate member including at least one electrode mounted thereon; and a tip member extending distally from a distal end of the elongate member, the tip member comprising a tapered portion tapering distally and a blunt end portion at a distal end of the tapered portion, wherein the tip member is resiliently flexible, and a method for making such a device.

Hearing prosthesis electrode array with resiliently flexible tip member

A method, including energizing one or more electrodes of a cochlear electrode array to induce a current flow in the cochlea at a plurality of temporal locations, measuring one or more electrical properties at one or more locations in the cochlea resulting from the induced current flow at the plurality of different temporal locations and determining whether or not trauma has occurred based on a change between the measured electrical properties from the first temporal location to the second temporal location.

Electrical techniques for biomarker detection in a cochlea

A medical implant, such as an implantable component () of a tissue-stimulating prosthesis. One example of such a prosthesis being a cochlear implant. The component () is adapted to be implanted at or adjacent a tissue surface within the recipient, such as a bone surface. The component () has a housing and at least one flange () extending outwardly therefrom. The flange () can be secured to the tissue surface via a tissue fixation device, such as a bone screw ().

Fixation system for an implantable medical device

An apparatus includes a stimulation assembly having an elongate body and a plurality of stimulation elements longitudinally spaced from one another along a portion of the elongate body. The stimulation assembly includes a first set of the stimulation elements and a second set of the stimulation elements. The apparatus further includes a tube over the second set of the stimulation elements. The tube is configured to be removed from the stimulation assembly.

Progressive insertion middle ear protector

An apparatus and method for implanting and securing an implanted medical device in a recipient. The implantable medical device of the generally includes an electrode assembly that comprises an elongate carrier member having at least one stimulating electrode positioned thereon. The carrier member further has a fixation structure positioned thereon configured to interact with a portion of the rigid structure to longitudinally secure the carrier member in the recipient.

Securing an implanted medical device in a patient

An implantable device for mounting to a patient's bone includes a housing and at least one osseointegrating protuberance. The housing includes a surface having an abutting portion configured to abut the bone when the housing is implanted in the patient, the abutting portion defining a housing axis orthogonal to the surface. The at least one osseointegrating protuberance: extends from the surface of the housing; is adapted to abut the patient's bone; and has a substantially smooth shaft.

Implantable device having one or more screws

Growing community of inventors

South Coogee, Australia

Peter Gibson